American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 – STRO-002 Abstract

by Asa Elmore | Apr 27, 2020 | News, Presentations

American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 – STRO-002 Abstract STRO-002-GM1, a first in human, phase 1 Study of STRO-002, an anti-Folate Receptor alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced...

Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate

by Asa Elmore | Apr 20, 2020 | Events, News, Presentations, Press Releases

Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate -Company to present updated STRO-002 data at AACR Virtual Annual Meeting – SOUTH SAN FRANCISCO, Calif., April 20, 2020 – Sutro...

Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020

by Asa Elmore | Apr 13, 2020 | Events, News, Presentations, Press Releases

Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020 – Company to host a conference call following the presentation – SOUTH SAN FRANCISCO, Calif., April. 13, 2020 –...

Sutro Biopharma Appoints James Panek to Board of Directors

by Asa Elmore | Jan 8, 2020 | News, Press Releases

Sutro Biopharma Appoints James Panek to Board of Directors SOUTH SAN FRANCISCO, Calif., Jan. 8, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...